Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
about
The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intakeCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateTargeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Marijuana use in hepatitis C infection does not affect liver biopsy histology or treatment outcomes.Glycyrrhizic acid attenuates CCl₄-induced hepatocyte apoptosis in rats via a p53-mediated pathwayMarijuana smoking does not accelerate progression of liver disease in HIV-hepatitis C coinfection: a longitudinal cohort analysisHybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosisRole of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.The endocannabinoid system in advanced liver cirrhosis: pathophysiological implication and future perspectives.Reversal of liver cirrhosis: current evidence and expectations.The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression.Cannabinoid receptors as therapeutic targets for dialysis-induced peritoneal fibrosis.Network analyses identify liver-specific targets for treating liver diseases.Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
P2860
Q26850858-371B1C80-ED79-4AA2-8E6F-C560E8B27188Q27027703-AF0569BB-6F17-46B1-A2DB-785812B9B0D3Q33655394-73D54051-D89D-4507-AC06-8B60F2514056Q34088634-5B8D4C76-FAE8-4A6A-96FE-78095A8E654DQ36975008-1A8B2BFC-BA80-40AA-A301-CC7BBB236CD1Q37085008-8B8C92C6-3CCB-4B1E-AB15-E003C79BA687Q37164508-7C220E0A-4ED1-4F56-BD75-878313787D3CQ37581457-5C42A0E9-CA75-4B0C-AED5-3015B1E290C9Q38124458-DEF98CA7-5EC2-47E5-8B76-9A2567F3E0CCQ38974002-2D05EA38-FDDA-4AD2-90FF-4888F9CA5740Q39031169-21B6208B-115B-4437-95B2-AE00FB6D59C4Q39215034-AF629CFC-6FBC-48A2-B6A5-0DF36856E73CQ41526807-5D4520CE-48FC-450A-969C-5293BE7DEB8DQ46319952-507C94E6-699F-4988-9B48-81BFF6E9D84F
P2860
Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl(4)-induced advanced cirrhosis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Reversal of liver fibrosis by ...... receptor in a rat model of CCl
@nl
Reversal of liver fibrosis by ...... 4)-induced advanced cirrhosis.
@en
type
label
Reversal of liver fibrosis by ...... receptor in a rat model of CCl
@nl
Reversal of liver fibrosis by ...... 4)-induced advanced cirrhosis.
@en
prefLabel
Reversal of liver fibrosis by ...... receptor in a rat model of CCl
@nl
Reversal of liver fibrosis by ...... 4)-induced advanced cirrhosis.
@en
P2093
P2860
P1476
Reversal of liver fibrosis by ...... 4)-induced advanced cirrhosis.
@en
P2093
Ferdinando A Giannone
Franco Trevisani
Marco Domenicali
Maurizio Baldassarre
Mauro Bernardi
Paolo Caraceni
P2860
P2888
P304
P356
10.1038/LABINVEST.2011.191
P577
2011-12-19T00:00:00Z